Participant recruitment in the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)

Controlled Clinical Trials

Volumn 22, Issue 6, 2001, Pages 674-686

  Pressel, Sara ^a   Davis, Barry R ^a   Louis, Gail T ^b   Whelton, Paul ^b   Adrogue, Horacio ^c   Egan, Debra ^d   Farber, Michael ^e   Payne, Gerald ^d   Probstfield, Jeffrey ^f   Ward, Harry ^g  

^a UNIVERSITY OF TEXAS SCHOOL OF PUBLIC HEALTH   (United States)

^b TULANE UNIVERSITY   (United States)

^c MICHAEL E DEBAKEY VETERANS AFFAIRS MEDICAL CENTER   (United States)

^d NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

^e Pitman Internal Medicine Associates   (United States)

^f UNIVERSITY OF WASHINGTON   (United States)

^g KING DREW MEDICAL CENTER   (United States)

Author keywords

Antihypertensive drug treatment; Clinical trial; Lipid lowering treatment; Patient recruitment

Indexed keywords

ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; AMLODIPINE; ANTIHYPERTENSIVE AGENT; ANTILIPEMIC AGENT; CALCIUM ANTAGONIST; CHLORTALIDONE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; DOXAZOSIN; LISINOPRIL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PRAVASTATIN;

ADULT; AGE; AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; FOLLOW UP; HEART INFARCTION; HIGH RISK POPULATION; HUMAN; HYPERCHOLESTEROLEMIA; MAJOR CLINICAL STUDY; MALE; MORTALITY; NEGRO; PATIENT CARE; PATIENT SELECTION; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME;

AGED; ANTIHYPERTENSIVE AGENTS; ANTILIPEMIC AGENTS; FEMALE; GOALS; HUMANS; MALE; MIDDLE AGED; MULTICENTER STUDIES; MYOCARDIAL INFARCTION; PERSONNEL SELECTION; RANDOMIZED CONTROLLED TRIALS; TIME FACTORS; UNITED STATES;

EID: 0035216013     PISSN: 01972456     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0197-2456(01)00177-5     Document Type: Article

References (12)

1. Recruitment for a Phase II trial of hypertension prevention. Effective strategies and predictors of randomization
2. Recruitment in the Trial of Nonpharmacologic Intervention in the Elderly (TONE)
3. Recruitment experience in the African-American Study of Kidney Disease and Hypertension (AASK) Pilot Study
4. Part 2: Screening and recruitment
5. Recruitment for Phase I of the trials of hypertension prevention
6. Recruitment for controlled clinical trials: Summary and annotated bibliography
7. Rationale, design, implementation, and baseline characteristics of patients in the DIG trial: A large, simple, long-term trial to evaluate the effect of digitalis on mortality in heart failure
8. Recruitment in the Studies of Left Ventricular Dysfunction (SOLVD): Strategies for screening and enrollment in two concurrent but different trials
9. Rationale and design for the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)
10. Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: The Scandinavian Simvastatin Survival Study (4S)
11. Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia
12. The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels